[go: up one dir, main page]

WO2001077353A3 - Proteines therapeutiquement actives dans des vegetaux - Google Patents

Proteines therapeutiquement actives dans des vegetaux Download PDF

Info

Publication number
WO2001077353A3
WO2001077353A3 PCT/EP2001/003788 EP0103788W WO0177353A3 WO 2001077353 A3 WO2001077353 A3 WO 2001077353A3 EP 0103788 W EP0103788 W EP 0103788W WO 0177353 A3 WO0177353 A3 WO 0177353A3
Authority
WO
WIPO (PCT)
Prior art keywords
plastids
expression
plants
pollen allergens
host
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2001/003788
Other languages
English (en)
Other versions
WO2001077353A2 (fr
Inventor
Peter Bernard Heifetz
Stephen Arthur Goff
Annmarie Bloom Tuttle
Monika Else Griot-Wenk
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syngenta Participations AG
Original Assignee
Syngenta Participations AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syngenta Participations AG filed Critical Syngenta Participations AG
Priority to AU2001252246A priority Critical patent/AU2001252246A1/en
Publication of WO2001077353A2 publication Critical patent/WO2001077353A2/fr
Publication of WO2001077353A3 publication Critical patent/WO2001077353A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
    • C12N15/8214—Plastid transformation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Botany (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Peptides Or Proteins (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)

Abstract

La présente invention concerne des plantes transgéniques exprimant des protéines thérapeutiquement actives, de préférence à partir de leur génome plasmidique ou ciblées sur le vacuole. Cette invention concerne aussi l'administration de ces plantes transgéniques à un hôte dans le cadre de la prévention ou du traitement de maladies. Dans un mode de réalisation préféré de l'invention, ces plantes ou ces matières dérivées de ces plantes sont administrées à cet hôte par voie orale.
PCT/EP2001/003788 2000-04-05 2001-04-03 Proteines therapeutiquement actives dans des vegetaux Ceased WO2001077353A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001252246A AU2001252246A1 (en) 2000-04-05 2001-04-03 Therapeutically active proteins in plants

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54361900A 2000-04-05 2000-04-05
US09/543,619 2000-04-05

Publications (2)

Publication Number Publication Date
WO2001077353A2 WO2001077353A2 (fr) 2001-10-18
WO2001077353A3 true WO2001077353A3 (fr) 2002-04-11

Family

ID=24168804

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2001/003788 Ceased WO2001077353A2 (fr) 2000-04-05 2001-04-03 Proteines therapeutiquement actives dans des vegetaux

Country Status (2)

Country Link
AU (1) AU2001252246A1 (fr)
WO (1) WO2001077353A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001021768A1 (fr) 1999-09-21 2001-03-29 Rutgers, The State University Of New Jersey Systeme de recombinaison specifique au site permettant de manipuler le genome du plaste de plantes superieures
US7186560B2 (en) 1999-09-21 2007-03-06 Rutgers, The State University Of New Jersey High level expression of immunogenic proteins in the plastids of higher plants
WO2002079409A2 (fr) 2001-03-29 2002-10-10 Rutgers, The University Of New Jersey Integrases permettant l'insertion d'acides nucleiques heterologues dans le genome plastidial
AU2004217489A1 (en) 2003-03-03 2004-09-16 Rutgers, The State University Of New Jersey Removal of plastid sequences by transiently expressed site-specific recombinases
WO2007121467A2 (fr) 2006-04-18 2007-10-25 Rutgers, The State University Of New Jersey Compositions et procédés destinés à augmenter l'expression de transgènes dans les plastes des plantes supérieures

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989001486A1 (fr) * 1987-08-11 1989-02-23 New York University Fragments de proteines bactericides/augmentant la permeabilite, biologiquement actifs
WO1994005790A1 (fr) * 1992-09-10 1994-03-17 Immulogic Pharmaceutical Corporation Clonage et sequençage d'allergenes de dermatophagoides (acariens de la poussiere)
WO1994010314A1 (fr) * 1992-10-30 1994-05-11 The University Of Melbourne Peptides et proteines allergenes obtenus a partir du pollen du sorgho d'alep
EP0770681A2 (fr) * 1992-04-09 1997-05-02 Immulogic Pharmaceutical Corporation Epitopes de lymphocytes T des principaux allergènes d'Ambrosia artemisiifolia
WO1998004274A1 (fr) * 1996-07-31 1998-02-05 University Of Manitoba Allergenes salivaires du moustique
WO1998006861A2 (fr) * 1996-08-15 1998-02-19 Agrivax Incorporated Administration d'antigenes tolerogeniques via des plantes comestibles ou des produits derives de plantes
WO2000020612A2 (fr) * 1998-10-07 2000-04-13 Syngenta Participations Ag Proteines vegetales a action therapeutique

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989001486A1 (fr) * 1987-08-11 1989-02-23 New York University Fragments de proteines bactericides/augmentant la permeabilite, biologiquement actifs
EP0770681A2 (fr) * 1992-04-09 1997-05-02 Immulogic Pharmaceutical Corporation Epitopes de lymphocytes T des principaux allergènes d'Ambrosia artemisiifolia
WO1994005790A1 (fr) * 1992-09-10 1994-03-17 Immulogic Pharmaceutical Corporation Clonage et sequençage d'allergenes de dermatophagoides (acariens de la poussiere)
WO1994010314A1 (fr) * 1992-10-30 1994-05-11 The University Of Melbourne Peptides et proteines allergenes obtenus a partir du pollen du sorgho d'alep
WO1998004274A1 (fr) * 1996-07-31 1998-02-05 University Of Manitoba Allergenes salivaires du moustique
WO1998006861A2 (fr) * 1996-08-15 1998-02-19 Agrivax Incorporated Administration d'antigenes tolerogeniques via des plantes comestibles ou des produits derives de plantes
WO2000020612A2 (fr) * 1998-10-07 2000-04-13 Syngenta Participations Ag Proteines vegetales a action therapeutique

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
BREITENEDER H ET AL: "THE GENE CODING FOR THE MAJOR BIRCH POLLEN ALLERGEN BETVL, IS HIGHLY HOMOLOGOUS TO A PEA DISEASE RESISTANCE RESPONSE GENE", EMBO JOURNAL, OXFORD UNIVERSITY PRESS, SURREY, GB, vol. 8, no. 7, 1 July 1989 (1989-07-01), pages 1935 - 1938, XP000050673, ISSN: 0261-4189 *

Also Published As

Publication number Publication date
AU2001252246A1 (en) 2001-10-23
WO2001077353A2 (fr) 2001-10-18

Similar Documents

Publication Publication Date Title
WO2000020612A3 (fr) Proteines vegetales a action therapeutique
WO2000078332A3 (fr) Proteinases de serine de poisson et leur utilisation pharmaceutique et cosmetique
WO2002056900A3 (fr) Utilisation de slpi pour traiter des maladies intestinales inflammatoires chroniques
ATE329608T1 (de) Formulierungen von copolymer 1 (glatirameracetat) zur oralen, nasalen und pulmonalen verabreichung
IL157652A (en) Metalloproteinase inhibitors, compositions comprising them and uses thereof for the preparation of medicaments for treating diseases or conditions mediated by metalloproteinase enzymes
NO20034612L (no) 3,4-di-substituerte syklobuten-1,2-dioner, farmasoytiske preparater som omfatter forbindelsene, samt anvendelse av forbindelsene for tilvirkning av medikamenter for behandling av kjemokinformidlede sykdommer
CA2431565A1 (fr) Nouvelles compositions pharmaceutiques a base d'anticholinergiques et de ciclesonide
NO20041277L (no) Farmasoytiske preparater for behandling av astma.
WO2004014953A3 (fr) Anticorps
WO2002028427A3 (fr) Composition pharmaceutique pour l'immunisation contre le sida
NO324227B1 (no) Cyclopropyl-kondenserte pyrrolidin-baserte forbindelser, farmasoytiske blandinger og kombinasjoner inneholdende slike samt anvendelse av slike for fremstilling av medikamenter for behandling av sykdommer
CA2392879A1 (fr) Derive de pyrrolidine acetamide seul ou combine pour traiter des affections du snc
IS6511A (is) Lyfjaefnablöndur sem innihalda sykurfitusýru estera til að stýra losun á virkum innihaldsefnum
CA2433833A1 (fr) Utilisation de flumazenil dans l'elaboration d'un medicament visant a traiter la dependence a l'alcool
WO2002017894A3 (fr) Utilisation d'une combinaison de salmeterol et de propionate de fluticasone
BR0210473A (pt) Composição compreendendo um inibidor da pde-4 e antagonista do receptor-h1 e seus usos na produção de um medicamento para o tratamento de doenças respiratórias
WO2001077353A3 (fr) Proteines therapeutiquement actives dans des vegetaux
WO2001076601A3 (fr) Compositions pharmaceutiques
MY145329A (en) Gastroresistant pharmaceutical dosage form comprising n-(2-(2-phthalimidoethoxy)-acetyl)-l-alanyl-d-glutamic acid (lk-423)
WO2001028535A3 (fr) Formulations pharmaceutiques
WO2005011602A3 (fr) Combinaison de dehydroepiandrosterone ou de sulfate de dehydroepiandrosterone et d'un inhibiteur de pde-4 pour le traitement de l'asthme ou d'une maladie obstructive respiratoire
WO2003024996A3 (fr) Macrocycles antibacteriens
AU2002333536A1 (en) Carboxylate-gated-nitroxide (cgn) compounds and compositions and methods of use thereof
CA2429793A1 (fr) Ameliorateur de l'effet therapeutique de l'interferon
WO2001051489A3 (fr) Procedes pour abaisser les niveaux d'acide urique

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP